Shares of cancer screening and diagnostic tests provider Exact Sciences Corporation (EXAS) are rising more than 17% Tuesday morning after the company said it has agreed to buy Thrive Earlier Detection Corp. for about $2.15 billion, cash and stock.
Thrive Earlier Detection Corp. is a healthcare company focused on incorporating earlier cancer detection into routine medical care.
The deal is expected to close during the first quarter of 2021.
The Exact Sciences shares touched a new high of $125.78 this morning.
For comments and feedback contact: editorial@rttnews.com
Business News
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.